This NDC is on FDA's drug shortage list (posted Mar 31, 2026)
Reported reason: Shortage of an inactive ingredient component
Product Information
FUROSEMIDE 10 MG/ML SOLUTION is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0920 per ML under NDC 00054329450. Its NADAC has been published 667 times since Nov 28, 2013.
FDA first approved this application on Apr 22, 1987.
Strength
10 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054329450
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA070434FDA Approved
4/22/1987
On Market Since
7/12/1988
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 10 MG/ML SOLUTION has been published 667 times since Nov 28, 2013, and over the history we have for it it has risen 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0920 per ML |
|---|---|
| All-time high | $0.1049 (Jun 15, 2022) |
| All-time low | $0.0766 (Mar 23, 2016) |
| 52-week high | $0.1028 |
| 52-week low | $0.0903 |
| Median price | $0.0967 |
| Average price | $0.0957 |
| Largest weekly change | +21.6% (Jun 19, 2024) |
| Weeks tracked | 667 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Furosemide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FUROSEMIDE 10 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 10 MG/ML SOLUTION, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0920 per ML (NDC 00054329450), effective Sep 30, 2026.
How has the price of FUROSEMIDE 10 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 10 MG/ML SOLUTION has risen 7.2%. It has been tracked across 667 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 10 MG/ML SOLUTION?
Since Nov 28, 2013, the NADAC for FUROSEMIDE 10 MG/ML SOLUTION has ranged from a low of $0.0766 (Mar 23, 2016) to a high of $0.1049 (Jun 15, 2022), with a median of $0.0967 per ML.
Are there cheaper alternatives to FUROSEMIDE 10 MG/ML SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FUROSEMIDE 10 MG/ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures FUROSEMIDE 10 MG/ML SOLUTION?
FUROSEMIDE 10 MG/ML SOLUTION (NDC 00054329450) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is FUROSEMIDE 10 MG/ML SOLUTION in shortage?
Yes — NDC 00054329450 is currently listed in FDA's drug shortage database (posted Mar 31, 2026). Reported reason: Shortage of an inactive ingredient component.